# v0.6.32 Static/Mock Applied Evidence Package Public Sample Promotion Decision Record

Version: v0.6.32 candidate  
Status: promotion decision record only; does not authorize runtime execution

## Purpose

This checkpoint records the promotion decision for the private-first static/mock
applied evidence package work.

v0.6.29 generated a private static/mock applied evidence package. v0.6.30 planned the
review and promotion gate. v0.6.31 generated a private review record with
`reviewed_keep_private`, `promotion_status = keep_private`, four scenarios, no
blocker categories, and public sample / runtime / scanner / customer-target /
delivery authorization remaining false.

v0.6.32 records the decision outcome: the private package remains private, direct
public sample generation remains blocked, and only a later sanitized public sample
planning checkpoint may be considered under separate review.

This checkpoint is promotion decision recording only.

This checkpoint does not promote public samples, generate public sample artifacts,
implement structural validators, execute structural validator checks, create runnable
configuration, create Docker Compose files, pull images, start containers, bind ports,
authorize Docker execution, authorize runtime execution, run scanners, inject
credentials, authorize customer-target operation, create customer deliverables,
provide certification, provide legal approval, or provide audit opinion.

## Public-safe design boundary

The promotion decision boundary is:

- AI output is treated as a request, not authority.
- AI may generate `tool_action_request`.
- Gates decide execution.
- Private generated artifacts remain private.
- Private review records remain private.
- Direct public sample generation remains blocked.
- A later sanitized public sample planning checkpoint may be considered.
- Planning consideration is not sample generation.
- Static/mock evidence is not live diagnostic evidence.
- Static/mock evidence is not proof of diagnostic accuracy.
- Customer-target operation remains blocked.
- Delivery authorization remains separately gated.
- Real local-lab diagnostic execution remains deferred.

Model output is not authority.

## Decision proposition

~~~text
The v0.6.31 private review result is sufficient to record a conservative decision:
keep the private static/mock package private, do not authorize public sample
generation, and allow only a later sanitized public sample planning checkpoint to be
considered under separate review.
~~~

This proposition is intentionally non-executing.

## Decision inputs

The decision is based on these inputs:

| Input | Source |
| --- | --- |
| Private static/mock package | v0.6.29 |
| Review and promotion gate planning | v0.6.30 |
| Private review record | v0.6.31 |
| Review status | `reviewed_keep_private` |
| Promotion status | `keep_private` |
| Scenario count | `4` |
| Blocker categories | `[]` |
| Public sample status | not generated |
| Runtime/scanner/customer/delivery authorization | false |

The inputs support planning consideration only, not public sample generation.

## Decision outcome

The decision outcome is:

~~~text
promotion_decision = keep_private_and_allow_public_sample_planning_consideration
public_sample_generation_authorized = false
public_sample_promotion_authorized = false
public_sample_planning_may_be_considered = true
runtime_execution_authorized = false
scanner_execution_authorized = false
customer_target_authorized = false
delivery_authorized = false
~~~

This outcome allows only the next planning discussion. It does not authorize generated
public artifacts.

## Rationale

The decision is conservative because:

- private generated artifacts have not been promoted,
- private review record remains private,
- structural validator implementation is still not present,
- public sample hygiene has not been independently planned,
- public naming and sample placement have not been decided,
- patent-sensitive detail review remains a separate concern,
- delivery authorization remains unrelated,
- real local-lab diagnostic execution remains deferred.

A separate planning checkpoint should exist before any public sample artifact is
created.

## Later planning conditions

A later sanitized public sample planning checkpoint should define:

- public sample scope,
- sanitized artifact names,
- public directory placement,
- synthetic-only content requirements,
- no-secret and no-credential checks,
- no-customer and no-third-party-target checks,
- no-live-scanner-output checks,
- patent-sensitive detail exclusion checks,
- non-proof statement visibility,
- AAEF five questions visibility,
- overclaim prevention checks,
- publication rollback posture.

Planning must precede public sample generation.

## Remaining blockers to public generation

Public sample generation remains blocked until a later checkpoint resolves:

- `public_sample_scope_not_defined`,
- `sanitized_artifact_naming_not_defined`,
- `public_directory_placement_not_defined`,
- `publication_hygiene_not_planned`,
- `patent_sensitive_review_not_recorded`,
- `structural_validator_not_implemented`,
- `public_non_proof_visibility_not_verified`,
- `public_overclaim_prevention_not_verified`,
- `human_publication_review_not_recorded`.

Every unresolved blocker prevents public generation.

## AAEF-side reporting note

AAEF-side reporting may state:

- v0.6.29 generated a private static/mock applied evidence package,
- v0.6.31 generated a private review record,
- review status was `reviewed_keep_private`,
- promotion status was `keep_private`,
- four scenarios were covered,
- blocker categories were empty,
- public sample generation remains unauthorized,
- runtime/scanner/customer-target/delivery authorization remains false,
- a later sanitized public sample planning checkpoint may be considered.

AAEF-side reporting should not expose private generated contents.

## Relationship to runtime execution

This checkpoint is unrelated to runtime execution enablement.

The following remain separate later tracks:

| Track | v0.6.32 status |
| --- | --- |
| Private static/mock package | exists privately |
| Private review record | exists privately |
| Public sanitized sample planning | may be considered later |
| Public sample generation | not authorized |
| Structural validator implementation | not implemented |
| Tool-backed local-lab diagnostic execution | deferred |
| Customer-target operation | blocked |
| Delivery authorization | blocked |

The earliest next step is public sample planning, not public sample generation and not
live diagnostic execution.

## Rollback posture

If later review finds publication risk:

- keep private package private,
- keep private review record private,
- do not create public sample artifacts,
- record blocker categories,
- revise generator or sample plan in a later checkpoint,
- preserve non-proof statements,
- preserve no-runtime and no-delivery boundaries.

Rollback is a safety control, not a failure.

## Recommended next checkpoint

The recommended next checkpoint is:

~~~text
v0.6.33 Sanitized Public Sample Planning
~~~

Rationale:

- v0.6.32 records that direct public generation is not authorized.
- A later checkpoint can plan a sanitized public sample without generating it.
- Public sample generation should remain a still later gated decision.
- Real local-lab diagnostic execution should remain deferred.

## Runtime and scanning boundary

This checkpoint does not change runtime authorization.

The following must remain false unless future explicit work changes the execution
authorization model:

~~~text
promotion_decision_recorded = true
public_sample_planning_may_be_considered = true
public_sample_generation_authorized = false
public_sample_promotion_authorized = false
public_sample_generated = false
public_artifact_generated = false
private_package_review_record_generated = true
structural_validator_implemented = false
structural_validator_checks_execute = false
tool_backed_diagnostic_capture_started = false
local_lab_diagnostic_system_built = false
fixture_live_evidence = false
validator_authorizes_execution = false
validator_authorizes_scanning = false
validator_authorizes_docker = false
validator_authorizes_delivery = false
docker_compose_file_created = false
docker_compose_executed = false
docker_image_pulled = false
container_started = false
port_bound = false
docker_execution_authorized = false
execution_authorized = false
runtime_execution_authorized = false
scanner_execution_authorized = false
real_execution_permitted = false
network_activity_allowed = false
scan_execution_allowed = false
credential_injection_permitted = false
customer_target = false
customer_target_authorized = false
external_network_target = false
delivery_authorized = false
customer_deliverable = false
~~~

## Claims to avoid

Avoid language implying that v0.6.32 promotes public samples, generates public sample
artifacts, provides real local-lab diagnostic evidence, provides live evidence, runs
scanners, creates Docker Compose files, approves Docker execution, pulls images,
starts containers, binds ports, approves production deployment, authorizes runtime
execution, authorizes scanning, permits credential injection, authorizes customer
targets, proves vulnerability detection accuracy, provides implementation conformance,
provides compliance certification, provides legal approval, provides audit opinion,
completes legal review, completes dependency audit, approves managed service use,
grants commercial license rights, guarantees safety, establishes external-framework
equivalence, provides audit sufficiency, provides legal sufficiency, approves public
samples, or authorizes delivery.

## Out of scope

This checkpoint does not promote public samples, generate public sample artifacts,
implement structural validators, execute structural validator checks, install Docker,
run Docker, pull images, start containers, bind ports, create Docker Compose files,
create a runnable Compose design, build a local lab, select a target for execution,
collect live preflight evidence, satisfy preflight, add dry-run lab execution, enable
runtime execution, enable scanning, add new scanner integrations, authorize report
delivery, expose private advanced feature details, create private sales material,
publish pricing, create a commercial contract, provide legal advice, authorize
external network testing, authorize credential injection, or authorize customer-target
testing.
